HealthTech

Eli Lilly Q1 2026 results reflecting tirzepatide sales surge, Mounjaro and Zepbound growth, and expanding GLP-1 drug market demand

Eli Lilly Posts 56% Revenue Surge as Incretin Empire Expands

Tirzepatide demand, oral GLP-1 approval, and raised full-year guidance confirm Eli Lilly's grip on the world's most consequential pharmaceutical franchise.

Tech IconsApr 30, 2026BiotechDrug DiscoveryPharmaceuticals

Novartis Q1 2026 earnings show Novartis Kisqali growth, Novartis Pluvicto sales, Novartis Entresto decline and Novartis pharma growth across Novartis drug portfolio, Novartis financial results, Novartis revenue and growth, Novartis oncology drugs, Novartis patent expiry impact, Novartis growth brands, Novartis drug sales growth and Novartis pharma strategy

Novartis Q1 2026 Earnings Show Growth Beyond Patent Cliff

Kisqali, Pluvicto, and Kesimpta posted combined growth above 50 percent, signalling that Novartis's post-patent transition is advancing faster than headline numbers suggest.

Tech IconsApr 28, 2026BiotechDrug DevelopmentPharmaceuticals

OpenAI pharmaceutical partnership Novo Nordisk AI drug discovery healthcare AI digital transformation Novo Nordisk OpenAI alliance AI strategy

Novo Nordisk and OpenAI Join Forces to Reshape Drug Discovery

The Danish pharmaceutical leader is embedding OpenAI's most advanced models across research, manufacturing, and commercial operations in a bid to accelerate its next era of growth.

Tech IconsApr 14, 2026BiotechnologyDrug DiscoveryHealthTech

Woman wearing a Whoop fitness tracker during an ice bath recovery session as Whoop launches its women’s health biomarker panel, integrating wearable data with women’s health biomarkers.

Whoop Launches Women’s Biomarker Panel as Femtech Surges

The Boston wearable pioneer's new blood biomarker panel targets female physiology, reflecting a broader industry shift where women's health has become both a scientific priority and a growth engine.

Tech IconsMar 13, 2026Digital HealthFemtechWearable Technology

Eli Lilly headquarters as weight-loss drugs Mounjaro and Zepbound drive record quarterly revenue

Lilly Delivers Record Q4 as Weight-Loss Drugs Rewrite Economics

Read more

The Strava app displayed on a smartphone, highlighting the platform’s activity tracking and social features ahead of its planned IPO.

Strava Files for IPO at $2.2B Valuation, $500M Revenue

Read more

Becky Quick, CNBC journalist and host, photographed in a studio setting ahead of the CNBC Cures Summit on rare disease research, Becky Quick brings rare disease innovation into focus through CNBC Cures, uniting science, patients and policy to accelerate genetic research.

Becky Quick and CNBC Cures: Advancing Rare Disease Innovation

Read more

President Donald Trump meets pharmaceutical executives at the White House as Medicare pricing reforms set the stage for oral Wegovy’s FDA approval.

Trump Administration Medicare Deal Powers Novo's Oral Rollout

Read more

Novartis global headquarters as the company announces a $1.7 billion AI drug discovery partnership with Relation Therapeutics.

Novartis Commits $1.7 Billion to AI-Driven Drug Discovery

Read more

Novo Nordisk’s public-facing operations now sit at the center of investor scrutiny as patent timelines tighten.

Novo Nordisk Meets a Patent Cliff as GLP-1 Dominance Weakens

Read more

Eli Lilly HQ, as it becomes the first trillion-dollar pharma company as GLP-1 therapies reshape global healthcare, competition, and long-term industry value.

Eli Lilly First Pharmaceutical Company to Reach $1T Valuation

Read more

President Donald Trump (L) and Health and Human Services Secretary Robert F. Kennedy Jr. (R) look on as Food and Drug Administration Commissioner Dr. Marty Makary (C) delivers remarks during an announcement by President Donald Trump on “significant medical and scientific findings for America’s children” in the Roosevelt Room of the White House on September 22, 2025 in Washington, DC

FDA Approves Leucovorin in Autism Speech Breakthrough

Read more

AI Cyberattacks Surge as Deepfakes and ML Breach Defenses

Workday Reports Data Breach Through Third-Party CRM System

Security Flaw in Perplexity's Comet AI Browser Exposes User Data

DDoS Attacks Overwhelm Global Digital Networks via IoT Botnets

AI Tools Turn Hackers Into Sophisticated Cybercrime Threat

Google Anthropic investment shows Alphabet AI strategy as Google invests in Anthropic through funding, valuation and cloud AI partnership driving enterprise AI growth, Claude adoption, revenue growth, compute deal and broader AI infrastructure investment

Google Backs Anthropic With Up to $40 Billion in New Capital

Read more

Meta layoffs AI strategy with job cuts, workforce reduction and restructuring in 2026 as cost cutting, headcount reduction and efficiency program fund capital spending, AI infrastructure, Superintelligence Labs and broader AI investment strategy and AI pivot across big tech

Meta Chooses Compute Over Headcount in Its Biggest AI Bet

Read more

Jeff Bezos Prometheus physical AI investment showing industrial AI systems robotics manufacturing models and large scale funding for physical world AI development

Jeff Bezos Builds the AI Lab That Industry Cannot Ignore

Read more